In STAD, CD93 expression inversely correlated with CD93 mutations and methylation, while positively associating with most immunosuppressive genes (such as PD-1, PD-L1, CTLA-4, and LAG3), immunostimulatory genes, HLA, chemokines, and chemokine receptors. This evidence concerns the gene CD93 and gastric adenocarcinoma.